Pfizer CEO: Trial Shows Booster Restores Full Protection

The Hill reports:

Pfizer and BioNTech announced on Thursday that a booster shot of their coronavirus vaccine restores full protection against COVID-19. The companies said that a late-stage clinical trial found that the booster was 95.6 percent effective against symptomatic COVID-19.

The efficacy results are the first from any randomized, controlled trial of a COVID-19 booster, they said. “These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease,” Pfizer CEO Albert Bourla said in a statement.

The trial followed 10,000 individuals aged 16 and older who were given either a booster dose or placebo on average 11 months after completing the initial two doses of the vaccine.

Read the full article.